Allogene Therapeutics Statistics
Total Valuation
ALLO has a market cap or net worth of $590.86 million. The enterprise value is $195.71 million.
| Market Cap | 590.86M |
| Enterprise Value | 195.71M |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024, after market close.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLO has 208.78 million shares outstanding. The number of shares has increased by 16.99% in one year.
| Shares Outstanding | 208.78M |
| Shares Change (YoY) | +16.99% |
| Shares Change (QoQ) | +0.39% |
| Owned by Insiders (%) | 17.54% |
| Owned by Institutions (%) | 64.47% |
| Float | 124.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9,090.13 |
| Forward PS | 10,719.34 |
| PB Ratio | 1.28 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3,010.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.80, with zero debt.
| Current Ratio | 12.80 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.90% and return on invested capital (ROIC) is -64.63%.
| Return on Equity (ROE) | -53.90% |
| Return on Assets (ROA) | -43.30% |
| Return on Capital (ROIC) | -64.63% |
| Revenue Per Employee | $279 |
| Profits Per Employee | -$1.26M |
| Employee Count | 233 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.69% in the last 52 weeks. The beta is 0.85, so ALLO's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -47.69% |
| 50-Day Moving Average | 2.57 |
| 200-Day Moving Average | 3.26 |
| Relative Strength Index (RSI) | 53.94 |
| Average Volume (20 Days) | 3,574,925 |
Short Selling Information
The latest short interest is 41.38 million, so 19.82% of the outstanding shares have been sold short.
| Short Interest | 41.38M |
| Short Previous Month | 43.28M |
| Short % of Shares Out | 19.82% |
| Short % of Float | 33.22% |
| Short Ratio (days to cover) | 11.97 |
Income Statement
In the last 12 months, ALLO had revenue of $65,000 and -$293.56 million in losses. Loss per share was -$1.82.
| Revenue | 65,000 |
| Gross Profit | 65,000 |
| Operating Income | -298.17M |
| Pretax Income | -293.56M |
| Net Income | -293.56M |
| EBITDA | -279.31M |
| EBIT | -293.56M |
| Loss Per Share | -$1.82 |
Balance Sheet
The company has $395.15 million in cash and no debt, giving a net cash position of $395.15 million or $1.89 per share.
| Cash & Cash Equivalents | 395.15M |
| Total Debt | n/a |
| Net Cash | 395.15M |
| Net Cash Per Share | $1.89 |
| Equity (Book Value) | 461.37M |
| Book Value Per Share | 2.21 |
| Working Capital | 364.47M |
Cash Flow
In the last 12 months, operating cash flow was -$226.99 million and capital expenditures -$489,000, giving a free cash flow of -$227.48 million.
| Operating Cash Flow | -226.99M |
| Capital Expenditures | -489,000 |
| Free Cash Flow | -227.48M |
| FCF Per Share | -$1.35 |
Margins
Gross margin is 100.00%, with operating and profit margins of -458,724.62% and -451,632.31%.
| Gross Margin | 100.00% |
| Operating Margin | -458,724.62% |
| Pretax Margin | -451,632.31% |
| Profit Margin | -451,632.31% |
| EBITDA Margin | -429,713.85% |
| EBIT Margin | -451,632.31% |
| FCF Margin | -349,972.31% |
Dividends & Yields
ALLO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.99% |
| Shareholder Yield | -16.99% |
| Earnings Yield | -49.68% |
| FCF Yield | -38.50% |
Analyst Forecast
The average price target for ALLO is $10.51, which is 271.38% higher than the current price. The consensus rating is "Buy".
| Price Target | $10.51 |
| Price Target Difference | 271.38% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 404.03% |
| EPS Growth Forecast (5Y) | -25.64% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALLO has an Altman Z-Score of -1.95 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.95 |
| Piotroski F-Score | 2 |